Basio, Jonathan .
HRN: 23-52-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/10/2023
08/16/2023
IVT
4.5 Mg
Q6
Cap Mr, COPD In Ae , Cor Pulmonale
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes